# RIVAROXABAN
> **ANDA218195** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2025-09-25
## Drug
- **FDA Application Number:** ANDA218195
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVAROXABAN
- **Generic name:** RIVAROXABAN GRANULE
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2025-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218195)
---
*AI Analytics · CC0 1.0*